A forum for researchers, students and applicants in the field of cyclodextrin technology
Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential
A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are neurodegenerative disorders characterised by cognitive dysfunction and neurological impairment. In
Researchers from Türkiye developed GE11-functionalized curcumin/carboxymethyl-β-cyclodextrin (Cur/CM-βCD) supramolecular assemblies, using GE11 as an EGFR-targeting peptide, to enhance the therapeutic potential
A new chapter in targeted cancer therapy On July 14, 2026, the U.S. FDA approved REVTORPYK™ (gedatolisib), developed by Celcuity,
Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are neurodegenerative disorders characterised by cognitive dysfunction and neurological impairment. In
BIOTEC-CHINA 2027 will be held from 23-25 April 2027 in Beijing Huanghe Jingdu Conference Center, Beijing China. BIOTEC-CHINA 2027 call
Researchers from the United States 🇺🇸 developed fast-dissolving HPβCD nanofibers containing a three-drug combination of aspirin, paracetamol, and caffeine commonly
What if decades-old human tissue archives could be transformed from thin, two-dimensional histological sections into detailed three-dimensional maps of cells,
This review on electrospinning investigates how this techniqe can be applied for delivering multiple drugs by allowing precise control over
Remdesivir (REM), a nucleoside analogue that has been approved for SARS-CoV-2 treatment, is poorly soluble in water and is currently
The Pharmaceutics 2027: From Biopharmaceutics to Clinical Pharmaceutics will take place in Barcelona, Spain from 28 to 30 June 2027. The following sessions are planned:
The Chinese group designed novel cyclodextrin-engineered bioinspired nanozyme (T-CD/Pt), and integrate it into a bi-regional microneedle (TP-MNs). Coupled with a
